Torres Denice — SEC insider filings

SEC reporting owner CIK 1820278. 32 insider filings on record with FilingPulse; latest filed 2026-11-04.

Transaction summary — filings shown

Covers all 32 filings on record, filed 2020-08-11 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Seaport Therapeutics, Inc. (SPTX)Director21 leg · 5,000 sh · $99,325—3
GLAUKOS Corp (GKOS)Director12——17
2seventy bio, Inc. (TSVT)Director5——13
Karuna Therapeutics, Inc. (KRTX)Director5——10
bluebird bio, Inc. (BLUE)Director3——8
Surface Oncology, Inc. (SURF)Director3——3
Celldex Therapeutics, Inc. (CLDX)Director2——2

Insider filings — Torres Denice

FiledFormIssuerReported transactionsSource
2026-11-044Seaport Therapeutics, Inc. (SPTX)Purchase (P): 5,000 @ $19.86EDGAR
2026-06-294Celldex Therapeutics, Inc. (CLDX)Grant/award (A): 26,000 (derivative) @ $0EDGAR
2026-06-234/AGLAUKOS Corp (GKOS)Grant/award (A): 2,987 (derivative) @ $0EDGAR
2026-06-014GLAUKOS Corp (GKOS)Grant/award (A): 1,878 @ $0 · Grant/award (A): 2,987 (derivative) @ $0EDGAR
2026-05-044Seaport Therapeutics, Inc. (SPTX)Conversion (C): 13,406 · Grant/award (A): 12,258 (derivative) @ $0 · Conversion (C): 42,105 (derivative) @ $0EDGAR
2026-01-074GLAUKOS Corp (GKOS)Grant/award (A): 623 @ $0EDGAR
2025-06-094Celldex Therapeutics, Inc. (CLDX)Grant/award (A): 33,000 (derivative) @ $0EDGAR
2025-06-024GLAUKOS Corp (GKOS)Grant/award (A): 461 @ $0 · Grant/award (A): 2,108 @ $0 · Grant/award (A): 3,149 (derivative) @ $0EDGAR
2025-05-1542seventy bio, Inc. (TSVT)Disposition to issuer (D): 12,050 · Code (U): 19,510 · Disposition to issuer (D): 24,100 (derivative)EDGAR
2024-06-1242seventy bio, Inc. (TSVT)Grant/award (A): 12,050 @ $0 · Grant/award (A): 24,100 (derivative) @ $0EDGAR
2024-06-034GLAUKOS Corp (GKOS)Grant/award (A): 1,716 @ $0 · Grant/award (A): 1,246 (derivative) @ $0EDGAR
2024-03-184Karuna Therapeutics, Inc. (KRTX)Disposition to issuer (D): 990 @ $330 · Disposition to issuer (D): 25,000 (derivative) @ $225.74 · Disposition to issuer (D): 8,500 (derivative) @ $201.99 · Disposition to issuer (D): 5,000 (derivative) @ $227.04 · Disposition to issuer (D): 1,904 (derivative) @ $92.30EDGAR
2024-01-044GLAUKOS Corp (GKOS)Grant/award (A): 895 @ $0EDGAR
2023-06-224Karuna Therapeutics, Inc. (KRTX)Grant/award (A): 990 @ $0 · Grant/award (A): 1,904 (derivative) @ $0EDGAR
2023-06-1542seventy bio, Inc. (TSVT)Grant/award (A): 8,400 @ $0 · Grant/award (A): 16,900 (derivative) @ $0EDGAR
2023-06-054GLAUKOS Corp (GKOS)Grant/award (A): 3,230 @ $0EDGAR
2023-01-044GLAUKOS Corp (GKOS)Grant/award (A): 1,572 @ $0EDGAR
2022-06-164Karuna Therapeutics, Inc. (KRTX)Grant/award (A): 5,000 (derivative) @ $0EDGAR
2022-06-104Surface Oncology, Inc. (SURF)Grant/award (A): 24,000 (derivative) @ $0EDGAR
2022-06-0942seventy bio, Inc. (TSVT)Grant/award (A): 8,200 @ $0 · Grant/award (A): 16,900 (derivative) @ $0EDGAR
2022-06-064GLAUKOS Corp (GKOS)Grant/award (A): 4,364 @ $0EDGAR
2022-01-054GLAUKOS Corp (GKOS)Grant/award (A): 1,455 @ $0EDGAR
2022-01-054Surface Oncology, Inc. (SURF)Grant/award (A): 12,000 (derivative) @ $0EDGAR
2021-11-174bluebird bio, Inc. (BLUE)Other (J): 1,476 @ $0 · Other (J): 0 @ $0 · Disposition to issuer (D): 4,500 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0EDGAR
2021-11-1642seventy bio, Inc. (TSVT)Grant/award (A): 492 @ $0 · Grant/award (A): 2,002 @ $0 · Grant/award (A): 1,476 (derivative) @ $0 · Grant/award (A): 3,219 (derivative) @ $0EDGAR
2021-08-034Surface Oncology, Inc. (SURF)Grant/award (A): 36,000 (derivative) @ $0EDGAR
2021-06-234Karuna Therapeutics, Inc. (KRTX)Grant/award (A): 8,500 (derivative) @ $0EDGAR
2021-06-174bluebird bio, Inc. (BLUE)Grant/award (A): 3,109 @ $0 · Grant/award (A): 5,000 (derivative) @ $0EDGAR
2021-06-074GLAUKOS Corp (GKOS)Grant/award (A): 2,382 @ $0EDGAR
2021-03-034GLAUKOS Corp (GKOS)Grant/award (A): 3,079 @ $0 · Grant/award (A): 449 @ $0EDGAR
2020-12-224Karuna Therapeutics, Inc. (KRTX)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2020-08-114bluebird bio, Inc. (BLUE)Grant/award (A): 2,250 @ $0 · Grant/award (A): 4,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1820278 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs